Approval · Notice of Compliance 10391 · 2009
MYLAN-ACYCLOVIR: Notice of Compliance 10391
Issued July 17, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10391
- Date
- July 17, 2009
- Company
- Mylan Pharmaceuticals UlcEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Antiviral agent
- Canadian reference product
- ZOVIRAX (Glaxo Wellcome Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MYLAN-ACYCLOVIR | 02242784 | Marketed |
| MYLAN-ACYCLOVIR | 02242463 | Marketed |
| MYLAN-ACYCLOVIR | 02242464 | Marketed |